4.5 Interaction with other med icinal products and other forms of interaction  
 No interacti on studies have been performed.  Strimvelis is not expected to interact with the hepatic cytochrome P-450 family of enzymes or  drug  transport ers.  
 Live vaccines  The safety of immunisation with live viral vaccines following Strimvelis treatment has not been studied. Vaccination with live virus vaccines is not recommended during the 6 weeks preceding the start of non-myeloablative conditioning, and until haematological and immunological recovery foll owing treatment with  Strimvelis.  
 
